$100/hour for advising pharma company - Advanced Prostate...

Advanced Prostate Cancer

22,355 members28,110 posts

$100/hour for advising pharma company

Darryl profile image
DarrylPartner
6 Replies

Myovant Sciences, Inc. is currently seeking patients living with

advanced and metastatic hormone-sensitive prostate cancer, and/or

their caregivers who may be interested in sharing their experiences

with the company.

Desired Patient/Caregiver Criteria:

* Living with or caring for someone living with advanced and

metastatic hormone-sensitive prostate cancer

* Adult 18 years of age or older

* Good relationship with their healthcare team

Call: 1-844-674-3520

or

Email: elizabeth@mypatientstory.com

Candidates will go through a screening process; therefore, there is a

chance not everyone screened will be able to participate. Participants

will be compensated for their time at $100/hour

Written by
Darryl profile image
Darryl
Partner
To view profiles and participate in discussions please or .
Read more about...
6 Replies
jmurgia profile image
jmurgia

I'll get on it later today. I'm almost having a second career with these interviews.

V10fanatic profile image
V10fanatic

Thanks for the information.

51na1a profile image
51na1a

May I call Friday to see if I may be eligible to participate

I would appreciate the opportunity to assist others and would have appretciated help In my current 5 -6 he (losing) battle.

Darryl profile image
DarrylPartner in reply to51na1a

Yes. Call Friday

51na1a profile image
51na1a

I did and glad I did.

I do desire to participate to my fullest.

JRPnSD profile image
JRPnSD

Initial contact when I called wanted too much personally identifiable information while being unable to give me any information on the nature of what they are doing. I will await a call back and some additional info, before sharing my info. I will share what I learn and comfort level with process.

Not what you're looking for?

You may also like...

Erleada in the EU for metastatic prostate cancer

The European Commission granted marketing authorization for Erleada to treat patients with...
Darryl profile image
Partner

FDA Approves Darolutamide Plus Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer

Other triple therapy approved by the FDA. The article has the basic results of the ARASENS trial....
tango65 profile image

Just hit the news stand

Interesting reading regarding nadir and other things.... Be sure to click on the charts....

UK - Abiraterone too expensive for non-CRPC mPCa?

"The United Kingdom’s National Institute for Health and Care Excellence (NICE) has chosen not to...
pjoshea13 profile image

Triplet therapy for mHSPC comes to the NHS!

Darolutamide + ADT in combination with docetaxel is to be used to treat patients (on the NHS) with...
Benkaymel profile image